Anthony Fauchi, chief expert in the fight against infectious diseases in the United States and advisor to US President Donald Trump in the battle against the spread of the emerging coronavirus, announced that the anti-viral drug Ramsdevir had a "clear" effect in treating the emerging coronavirus.
He said from the White House that "the data show that Ramsdevir has left a clear, important and positive effect in reducing the recovery period" of the patients of the emerging coronavirus.
The expert added that this matter proves that "a drug cannot respond to the virus."
A clinical study of this drug was carried out in cooperation between the American Institutes of Health and the American Gilead Laboratory.
But another study conducted in China and published today, Wednesday, stated that the drug did not give important benefits in treating Covid-19 patients, and Dr. Fuchi considered it "not a proper study."